why choose us

First received: August 12, 2024

Clinical Trial: Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: PAH

Study Type: INTERVENTIONAL


Official Title: Single Dose Oral Bioequivalence Study of Macitentan and Tadalafil Filmcoated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg in Health

Brief Summary: Single dose oral bioequivalence study of Macitentan and Tadalafil film-coated tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil film-coated tablets 10 mg/40 mg in healthy adult male subjects under fed conditions.

Read more